Option Care Health Posts Q2 EPS of 35c, Beating Expectations
OPCH sits 36% above its 52-week low of $18.01.
Summary
Option Care Health reported Q2 EPS of 35c, a solid beat against the backdrop of mixed Q1 results and a recent Chief Growth Officer departure. The company had already raised full-year Adjusted EPS guidance to $1.85–$1.92 in an 8-K filed earlier today, and this quarterly print confirms the momentum behind that raise. Revenue reached $1.44 billion, consistent with the earlier filing. With a $1 billion buyback program in place and shares at $24.51, the earnings beat reinforces the bullish guidance and could drive further repurchase activity.
At the time of this announcement, OPCH was trading at $24.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $18.01 to $36.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.